BIIB
Biogen·NASDAQ
--
--(--)
--
--(--)
4.45 / 10
Netural
Liquidity flow evaluation: 7.69/10 demonstrating robust fund flow characteristics. Optimistic no significant trends patterns are mitigated by pessimistic overall, block, Small, Medium, Large, and Extra-large indicators, pointing to positive flow perspective. Professional analyst opinion suggests predominantly positive analyst sentiment, showing moderate confidence. Distribution pattern: Buy(50.0%), Neutral(50.0%) based on 2 research evaluations, supported by 1.21 historical weighted rating.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-27
InstitutionCitigroup
Times predicted4
Historical Win Rate50.0%
What is the analyst consensus for BIIB?
- BIIB holds a Bearish analyst rating, with 50% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.45/10 (Netural).
